Data / Form D filings / CALVIRI INC
CALVIRI INC: Form D filings
CALVIRI INC, a biotechnology company in Phoenix, AZ, filed 9 Form D notices with the SEC between 2019 and 2024. The latest, on November 12, 2024, reports $785,004 sold of a $5 million offering to 10 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 850 N 5TH ST., Phoenix, AZ, 85004
- Phone
- (480) 205-6436
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1763612
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 12, 2024 | New notice | $5,000,000 | $785,004 | $4,214,996 | 10 | Oct 24, 2024 | sec.gov |
| Sep 24, 2024 | New notice | $2,000,000 | $150,000 | $1,850,000 | 1 | Sep 6, 2024 | sec.gov |
| Oct 4, 2023 | New notice | $30,000,000 | $650,232 | $29,349,768 | 3 | Sep 20, 2023 | sec.gov |
| May 9, 2023 | Amendment | $11,082,000 | $11,081,708 | $292 | 32 | Oct 28, 2021 | sec.gov |
| Nov 12, 2021 | New notice | $10,000,000 | $5,150,003 | $4,849,997 | 14 | Oct 28, 2021 | sec.gov |
| Oct 20, 2020 | New notice | $5,000,000 | $2,430,002 | $2,569,998 | 5 | Sep 24, 2020 | sec.gov |
| Oct 15, 2020 | New notice | $5,000,000 | $430,002 | $4,569,998 | 3 | Sep 24, 2020 | sec.gov |
| Mar 6, 2020 | Amendment | $2,250,000 | $1,875,000 | $375,000 | 4 | Dec 20, 2018 | sec.gov |
| Jan 7, 2019 | New notice | $2,250,000 | $1,500,000 | $750,000 | 3 | Dec 20, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kathryn Albert Sykes | Director | |
| Jeffrey J. Le Benger | Director | |
| Michael J. McCallister | Director | |
| Stephen Albert Johnston | Executive Officer, Director | |
| Jacque J. Sokolov | Director |
Other biotechnology companies in Arizona that filed recently
- Gut-Brain-Axis Therapeutics Inc. $2 million · Oct 27, 2026
- Avery Therapeutics, Inc. $8.5 million · Sep 21, 2026
Every Form D from the week of Nov 11, 2024 · All recent filings in Arizona · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what CALVIRI INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.